JAKARTA. PT Kalbe Farma Tbk (KLBF) plans to sustain its sales growth target this year of 11%, aiming for over IDR 29 trillion. The company has laid out different strategies to reinforce its distribution and logistics business line as the primary contributor to its sales.
Vidjongtius, President Director of Kalbe Farma, confirmed that the distribution and logistics segment is still projected to be the main contributor to KLBF’s consolidated net sales. For the record, throughout the first semester of 2022, said segment covered 37% of total net sales of KLBF, followed by the nutrition segment of 27%, prescribed drugs of 21%, and health products of 15%. KLBF currently has three regional distribution centres, 71 branch offices, and over 200,000 outlets across the country, all ready to support products sales.
In order to solidify its distribution and logistics business, KLBF continues to improve the facilities of its existing branch offices in order to enhance the service quality, extend the warehouse capacity, and collaborate with sub-distributors to gain more scope.
For more information, KLBF aims to secure IDR 29.15 trillion of sales this year, whereas its net sales in 2021 reached IDR 26.26 trillion. In the first half of 2022, KLBF’s net sales rose 12.2% year-on-year (yoy) to IDR 13.87 trillion, as did its net profit of 9.3% yoy to IDR 1.63 trillion. (AM/ZH)